Picture of Halma logo

HLMA Halma News Story

0.000.00%
gb flag iconLast trade - 00:00
TechnologyBalancedLarge CapHigh Flyer

REG - Halma PLC - Acquisition

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260413:nRSM0793Aa&default-theme=true

RNS Number : 0793A  Halma PLC  13 April 2026

 

Halma plc ('Halma' or the 'Group')

Acquisition

 

Halma, the global group of life-saving technology companies focused on growing
a safer, cleaner, healthier future for everyone, every day, today announces
that it has acquired Surgistar, Inc. (Surgistar) as a bolt-on for its
Healthcare Sector company, MicroSurgical Technology, Inc. (MST).

 

Founded over 20 years ago and based in California, Surgistar designs and
manufactures ophthalmic surgical instruments and devices. Its product
portfolio includes blades, cannulas and trephines, which are manufactured
using highly automated processes that help ensure consistent quality and
sharpness.

 

The cash consideration for Surgistar is $90m (approximately £67m), on a cash-
and debt-free basis, to be funded from Halma's existing facilities.

 

Marc Ronchetti, Group Chief Executive of Halma, commented: "Surgistar's
differentiated product range is highly complementary to MST's and further
strengthens Halma's ophthalmic product offering. The acquisition enhances
MST's manufacturing capabilities and supports its long-term growth through
MST's existing direct and global channels. We are excited to see our existing
companies expand their capabilities through bolt-on acquisitions and delighted
to welcome Surgistar to Halma."

 

For further information, please contact:

 

Halma plc

Marc Ronchetti, Group Chief Executive
 +44 (0)1494 721 111

Carole Cran, Chief Financial Officer
     +44 (0)1494 721 111

Melanie Horton, Co-Head of Investor Relations               +44 (0)
7554 013 396

Charles King, Co-Head of Investor Relations                   +44 (0)
7776 685 948

 

MHP

Oliver Hughes / Rachel Farrington / Ollie Hoare              +44
(0)7817 458 804 / halma@mhpgroup.com

 

A copy of this announcement, together with other information about Halma, may
be viewed on our website www.halma.com (http://www.halma.com/) .

 

About Halma

Halma is a global group of life-saving technology companies, focused on
growing a safer, cleaner, healthier future for everyone, every day. Its
purpose defines the three broad market areas where it operates:

 

 ·    Safety           Protecting the safety of people and assets as populations grow and the demand
                       on infrastructure increases.
 ·    Environment      Addressing the impacts of climate change, pollution and waste, protecting
                       life-critical resources and supporting scientific research.
 ·    Healthcare       Meeting the increasing demand for better healthcare as chronic illness rises,

                     driven by growing and ageing populations and lifestyle changes.

 

Halma employs over 9,000 people in more than 20 countries, with major
operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is
listed on the London Stock Exchange (LON: HLMA) and is a constituent of the
FTSE 100 index.

 

Halma has been named as one of Britain's Most Admired Companies for the past
seven years.

 

For more information www.halma.com (http://www.halma.com/) .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACQIBMITMTTBBIF



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Halma

See all news